Abstract
Cranial magnetic resonance imaging (MRI) was performed in nine treated adolescents with hyperphenylalaninaemia (HPA) in order to analyse possible changes in myelination. Three patients suffered from type I HPA, four from type II and two from type III (persistent HPA). Images were obtained with a 1.5T unit using spin-echo-sequences. In all patients with type I or type II HPA, abnormal findings in the cerebral white matter were demonstrated including band-like and/or confluent patchy areas of high signal intensity predominantly in the peritrigonal region, with anterior and posterior periventricular extension and/or involvement of the subcortical white matter. The extent of MRI changes did not correlate with the initiation, duration or quality of dietary treatment. There was also no consistent relationship between electrophysiological changes and white matter abnormalities on MRI. Our findings suggest a disturbance of myelination in patients with treated HPA. These results correspond well with earlier neuropathological and biochemical studies in untreated patients.
Similar content being viewed by others
Abbreviations
- HPA:
-
hyperphenylalaninaemia
- MRI:
-
magnetic resonance imaging
- PAH:
-
phenylalanine hydroxylase
- Phe:
-
phenylalanine
- PKU:
-
phenylketonuria
References
Barkovich AJ, Kjos BO, Jackson DE, Norman D (1988) Normal maturation of the neonatal and infant brain: MR imaging at 1.5T. Radiology 166:173–180
Bauman ML, Kemper TL (1982) Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol (Berl) 58:55–63
Behbehani AW, Krtsch H, Schulte FJ (1981) Cranial computerized tomography in phenylketonuria. Neuropediatrics 12:295–302
Bick U, Fahrendorf G, Ludolph A, Ullrich K (1989) MR imaging of the brain in patients with hyperphenylalaninemia. Presented at the 27th SSIEM annual meeting in Munich. Abstracts of the 27th SSIEM Annual Symposium, p 023
Bird CR, Hedberg M, Drayer BP, Keller PJ, Flom RA, Hodak JA (1989) MR assessment of myelination in infants and children: usefulness of marker sites. AJNR 10:731–740
Bodis-Wollner I, Onofrij M (1986) The visual system in Parkinson's disease. Adv Neurol 45:323–327
Brant-Zawadzki M (1988) MR imaging of the brain. Radiology 166:1–10
Brody BA, Kinney HC, Kloman AS, Gilles FH (1987) Sequence of central nervous system myelination in human infancy. I. An autopsy study of myelination. J Neuropathol Exp Neurol 46:283–301
Davison AN, Dobbing J (1966) Myelination as a vulnerable period in brain development. Br Med Bull 22:40–44
Dietrich RB, Bradley WG, Zaragoza EJ, Otto RJ, Taira RK, Wilson GH, Kangarloo H (1988) MR evaluation of early myelination patterns in normal and developmentally delayed infants. AJNR 9:69–76
Fishler K, Gross Friedman E, Azen CG, Koch R (1985) Psychoeducational outcome in treated PKU children. In: Bickel H, Wachtel U (eds) Inherited diseases of amino acid metabolism. Thieme, Stuttgart, pp 163–169
Goodin DS, Rowley HA, Olney RK (1988) Magnetic resonance imaging in amyotrophic lateral sclerosis. Ann Neurol 23:418–420
Hommes FA (1985) Myelin turnover at later stages of brain development on experimental hyperphenylalaninemia. In: Bickel H, Wachtel U (eds) Inherited diseases of amino acid metabolism. Thieme, Stuttgart, pp 67–83
Huether G, Kaus R, Neuhoff V (1982) Brain development in experimental hyperphenylalaninaemia: myelination. Neuropediatrics 13:177–182
Kakulas BA, Hamilton GJL, Mastaglia FL (1968) Clinical and neuropathological observations in phenylketonuria. Proc Aust Assoc Neurol 5:155–158
Kinney HC, Brody BA, Kloman AS, Gilles FH (1988) Sequence of central nervous system myelination in human infancy. J Neuropathol Exp Neurol 47:217–234
Koch R, Gross Friedman E, Azen CG, Williamson ML, Donnell GN (1985) Report from the United States collaborative study of children treated for phenylketonuria (PKU). In: Bickel H, Wachtel U (eds) Inherited diseases of amino acid metabolism. Thieme, Stuttgart, pp 134–149
Koch R, Azen CG, Hurst N, Gross Friedman E, Fishler K (1987) The effects of diet discontinuation in children with phenylketonuria. Eur J Pediatr 146 [Suppl 1]:A12-A16
Krause W, Halminski M, McDonald L, Dembure P, Salvo R, Freides D, Elsas L (1985) Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. J Clin Invest 75:40–48
Lane JD, Neuhoff V (1980) Phenylketonuria. Clinical and experimental considerations revealed by the use of animal models. Naturwissenschaften 67:227–233
Martin JJ, Schlote W (1972) Central nervous system lesions in disorders of amino-acid metabolism. A neuropathological study. J Neurol Sci 15:49–76
Mirowitz S, Sartor K, Gado M, Torack R (1989) Focal signalintensity variations in the posterior internal capsule: normal MR findings and distinction from pathologic findings. Radiology 172:535–539
Nowell MA, Grossman RI, Hackney DB, Zimmerman RA, Goldberg HI, Bilaniuk LT (1988) MR imaging of white matter disease in children. AJR 151:359–365
Press GA, Barshop BA, Haas RH, Nyhan WL, Glass RF, Hesselink JR (1989) Abnormalities of the brain in nonketotic hyperglycinemia: MR manifestations. AJNR 10:315–321
Salguero LF, Itabashi HH, Allen RJ (1968) Neuropathologic observations in phenylketonuria. Trans Am Neurol Assoc 93: 274–276
Schmidt H, Mahle M, Michel U, Pietz J (1987) Continuation vs discontinuation of low-phenylalanine diet in PKU adolescents. Eur J Pediatr 146 [Suppl 1]:A17-A19
Schmidt H, Lutz P, Batzler U (1989) Differentialdiagnose des erhöhten Phenylalanin-Blutspiegels im Säuglingsalter. Monatsschr Kinderheilkd 137:86–92
Scriver CR, Kaufman S, Woo SLC (1989) The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease I, 6th edn. McGraw-Hill, New York, pp 495–546
Trefz FK, Schmidt H, Bartholomé K, Mahle M, Matthis P, Pecht G (1985) Differential diagnosis and significance of various hyperphenylalaninemias. In: Bickel H, Wachtel U (eds) Inherited diseases of amino acid metabolism. Thieme, Stuttgart, pp 86–100
Valk J, Knaap MS van der (1989) Magnetic resonance of myelin, myelination and myelin disorders. Springer Verlag, Berlin Heidelberg New York
Villasana D, Butler IJ, Williams JC, Roongta SM (1989) Neurological deterioration in adult phenylketonuria. J Inherited Metab Dis 12:451–457
Waisbren SE, Schnell RR, Levy HL (1980) Diet termination in children with phenylketonuria: a review of psychological assessments used to determine outcome. J Inherited Metab Dis 3:149–153
Williams RS, Hauser SL, Purpura DP, DeLong GR, Swisher CN (1980) Autism and mental retardation. Neuropathologic studies performed in four retarded persons with autistic behavior. Arch Neurol 37:749–753
Williamson ML, Koch R, Azen CG, Gross Friedman E (1985) Diet termination: matched pair control between PKU children and their non-PKU siblings. In: Bickel H, Wachtel U (eds) Inherited diseases of amino acid metabolism. Thieme, Stuttgart, pp 151–162
Zimmermann RD, Fleming CA, Lee BCP, Saint-Louis LA, Deck MDF (1986) Periventricular hyperintensity as seen by magnetic resonance: prevalence and significance. AJNR 7:13–20
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bick, U., Fahrendorf, G., Ludolph, A.C. et al. Disturbed myelination in patients with treated hyperphenylalaninaemia: evaluation with magnetic resonance imaging. Eur J Pediatr 150, 185–189 (1991). https://doi.org/10.1007/BF01963563
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01963563